Tessa Sleep Quality Monitoring - ABSTRACT
TessaTM is validated medical device wearable capable of providing
clinical sleep quality metrics for multiple nights to assess the efficacy of
a sleep disorder treatment. Tessa records the forehead EEG to stage
sleep in an automated report that tracks changes in sleep architecture
before and after a treatment for many sleep disorders such as
obstructive sleep apnea and insomnia. There is a trend for tracking
one’s sleep health at home with unvalidated consumer electronic
wearables. Yet, sleep diaries, actigraphy watches, and smart phone
sleep apps have been shown to be inadequate, inaccurate, and have
poor specificity as compared to polysomnography (PSG). There is clear
need for a validated medical device that can provide primary care
physicians and sleep medicine specialists with clinically-actionable,
quantitative information on a person’s sleep architecture with the
sensitivity and specificity of PSG for multiple nights in the user’s home. TessaTM is a medical device worn on
the forehead at night to track sleep
To address this clear medical need, Epitel has developed a prototype quality by monitoring the EEG. Its
of its Tessa device that records EEG from two gold electrodes centered form and compliance make it
above the eyes with a common reference along the midline based on comfortable to wear and sleep with for
frontal scalp locations that have been shown to contain the EEG multiple nights in the user’s home.
signatures of sleep architecture, including eye movements
(Stepnowsky et al, 2013; Huang et al, 2014; Popovic et al, 2014). Tessa
is simply placed on the forehead each night where it records the EEG
signatures of the different sleep stages. Each night, a fresh conductive
and adhesive “sticker” is placed on the bottom of the device. Each
morning, Tessa is removed from the forehead and the
conductive/adhesive sticker is peeled off and thrown away. After use,
Tessa is mailed back to Epitel where accredited sleep technicians
generate a personalized sleep quality report that becomes part of the
user’s electronic medical records.
Tessa is semi-disposable, designed
The goal of this Phase I study is to demonstrate the feasibility of Tessa to be used for up to 90 nights. A
in two scenarios inside and outside the Sleep-Wake Center at the nightly disposable conductive and
University of Utah: adhesive sticker (not shown) is
i. Tessa records functionally equivalent EEG sleep metric data to placed over the gold electrodes
the “gold-standard” polysomnography (bottom). Tessa will be molded in a
ii. Demonstrate Tessa feasibility for at-home monitoring flexible medical-grade polyamide to
create a robust waterproof interface
With the Tessa prototype we have successfully recorded the five
suitable for the rigors of home use.
different stages of sleep over multiple nights.
In Aim 1 we will compare Tessa recordings to
the gold standard PSG in the Sleep-Wake
Center to demonstrate sensitivity and
specificity for accurately identifying the
different stages of sleep. In Aim 2 we will take
Tessa out of the Sleep Center and into the
person’s home environment to demonstrate
the feasibility of making EEG recordings with
Tessa for 10 nights. With this feasibility data,
Epitel will in Phase II, finalize the design to
make Tessa suitable for the rigors of home
use, culminating in a validation clinical trial for
FDA-clearance through the 510(k) process.
Recording 2-Ch EEG from the forehead with
Tessa, challenges and seeks to shift clinical EEG recordings from the Tessa prototype show the different
sleep quality monitoring practice by bringing stages of sleep architecture, demonstrating the ability to stage
multi-night sleep staging to the user’s home. sleep from two channels of frontal EEG.